Stay updated with breaking news from Platelet Activation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
THE WOODLANDS, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that four data presentations related to sotagliflozin, an inhibitor of two sodium glucose transport
Extracellular vesicles (EVs) have great potential for influencing the diagnosis of diseases such as cancer and may provide solutions for therapeutics. These unique cell-secreted particles, ranging from a few nanometers to a few microns in diameter, offer an exclusive insight into the cellular world. Their involvement in removing material from the cell and their delivery to recipient cells has them carrying proteins, lipids, and RNAs, a goldmine of potential biomarkers. In fact, in 202
Extracellular vesicles (EVs) have great potential for influencing the diagnosis of diseases such as cancer and may provide solutions for therapeutics. These unique cell-secreted particles, ranging from a few nanometers to a few microns in diameter, offer an exclusive insight into the cellular world. Their involvement in removing material from the cell and their delivery to recipient cells has them carrying proteins, lipids, and RNAs, a goldmine of potential biomarkers. In fact, in 202
Presentations on Additional REDUCE-IT® Sub-Population, In-Vitro Data on EPA to Be Featured at the CongressDUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc
Presentations on Additional REDUCE-IT Sub-Population, In-Vitro Data on EPA to Be Featured at the Congress